Salesforce earnings are doing little to break stock out of slump. Some major analysts think a big AI rally is ahead

Salesforce topped expectations in fiscal Q3 with adjusted EPS of $3.25 versus the $2.86 LSEG consensus and guided Q4 revenue of $11.13–11.23 billion versus Street estimates of ~$10.9 billion, even as the stock is down ~29% year-to-date. Analysts highlighted improving bookings, 11% cRPO growth (vs guidance 9%), and early Agentforce/Data Cloud AI momentum as catalysts for reacceleration, while several firms raised price targets—ranging from Bernstein's $223 to Morgan Stanley's $405—reflecting divergent views on medium-term growth, M&A risk and buyback-driven returns. The report presents a potential buying opportunity for bullish investors but leaves room for caution as AI revenue contribution remains early and investors await additional quarters of evidence.

Analysis

Market structure: Salesforce (CRM) is a potential beneficiary if Agentforce/Data Cloud convert bookings into cRPO and subscription revenue; that would shift share toward incumbents able to bundle AI into sticky SaaS. Near-term winners include AI infra/stack providers (NVDA, MSFT, GOOG) and large systems integrators; losers are smaller point-solution CRM/analytics vendors and any high-multiple pure-play AI apps that rely on enterprise spend. Positive FCF/repurchase cadence should tighten credit spreads modestly and reduce CDS premia; expect modestly higher implied equity vols near earnings and a small bull steepening in IG credit curves if momentum continues.

Risk assessment: Key tail risks are (1) Agentforce adoption failure or measurably lower sales productivity leading to a >20–30% EPS revision over 12 months, (2) a large expensive M&A that dilutes FCF/EBITDA by >10% and destroys investor confidence, and (3) regulatory/data-privacy constraints on monetizing Data Cloud. Immediate (days) moves will be sentiment-driven; short-term (3–6 months) hinge on booking metrics (cRPO trends); long-term (12–24 months) depends on AI revenue scaling from current ~$200M q/q to multiple billions.

Trade implications: Tactical allocation is to position for a FY27 reacceleration while protecting against near-term execution risk. Consider a core-long with defined downside protection (size 2–3% NAV, target +50–70% in 12–24 months) and hedges via puts or call-spreads; pair trades (long CRM, short NOW) can express idiosyncratic CRM upside vs. peer re-rating. Rotate 2–4% from speculative AI apps into AI infra (NVDA, MSFT) and trim non-core legacy software exposure.

Contrarian angles: Consensus expects AI to drive reacceleration but underestimates integration/time-to-monetize risk — $200M q/q is material but still small vs. $50B TAM targets; the market may be underpricing the probability of execution failure (implying >30% downside). The bullish read-through to CRM from broader AI euphoria may be overdone near-term; a disciplined approach (buy on any pullbacks to <$210, or add on confirmed cRPO inflection over two quarters) captures mispricing without taking unbounded risk.